[1]
Khalikova, A. et al. 2025. Prognostic Significance of Biomarkers of Inflammation and Myocardial Fibrosis in Assessing Response to Cardiac Resynchronization Therapy. Journal of Heart Disease and Therapy. 2, 01 (May 2025), 21–24. DOI:https://doi.org/10.71295/JHDT.2025.020105.